Hematology/Oncology

Top Story

Multiple mental health symptoms common in adolescent cancer survivors

Multiple mental health symptoms common in adolescent cancer survivors
July 27, 2016

Adolescent survivors of childhood cancers frequently experienced concurrent behavioral, emotional and social deficits, according to research published in Journal of Clinical Oncology.

These comorbidities often resulted from treatment exposures and physical late effects, results showed.

In the Journals Plus

Local peripheral therapies improve efficacy of ipilimumab for melanoma

July 27, 2016
The addition of ipilimumab to local peripheral treatments significantly extended OS in patients with melanoma, according to the results of a retrospective clinical…
In the Journals Plus

Open, robotic prostatectomy produce similar early functional outcomes

July 26, 2016
Robotic-assisted laparoscopic prostatectomy and open radical prostatectomy demonstrated similar 3-month postoperative outcomes for patients with localized prostate…
Supplement

Meeting Update: ASCO highlights therapeutic advances in multiple cancer subtypes

HemOnc Today, July 25, 2016
Meeting Update: ASCO highlights therapeutic advances in multiple cancer subtypes Supplement
In the Journals

USPSTF finds insufficient evidence in favor of screening for skin cancer

July 26, 2016
There is not sufficient evidence to recommend visual skin examination by a clinician in screening for skin cancer in asymptomatic adults, the U.S. Preventive Services…
More News Headlines »
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Video

VIDEO: James L. M. Ferrara, MD, DSc, reviews “long-standing problem” of GVHD after allogeneic HSCT

July 14, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty-five percent of lung cancers are non-small…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan